We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-11.74%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$171M
AUM Growth
+$26.4M
Cap. Flow
+$41.2M
Cap. Flow %
24.02%
Top 10 Hldgs %
46.38%
Holding
55
New
23
Increased
12
Reduced
8
Closed
12

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.15M
2
EW icon
Edwards Lifesciences
EW
+$5.35M
3
ZBH icon
Zimmer Biomet
ZBH
+$5.16M
4
LLY icon
Eli Lilly
LLY
+$4.99M
5
ACRS icon
Aclaris Therapeutics
ACRS
+$3.53M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$8.8M
2
PHG icon
Philips
PHG
+$7.46M
3
CAH icon
Cardinal Health
CAH
+$4.7M
4
MEDP icon
Medpace
MEDP
+$3.46M
5
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
+$2.84M

Sector Composition

Rank Sector Weight
1 Healthcare 43.72%
2 Industrials 3.39%
3 Financials 1.45%
4 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
26
CALL
Boston Scientific
BSX
$68.5B
$2.61M 1.52%
+120,500
New +$2.63M
UNH icon
27
UnitedHealth
UNH
$389B
$2.59M 1.51%
16,187
+1,138
+8% +$170K
HUM icon
28
PUT
Humana
HUM
$46.7B
$2.55M 1.49%
+12,500
New +$2.38M
AET
29
DELISTED
Aetna Inc
AET
$2.48M 1.45%
+20,000
New +$2.39M
BSX icon
30
Boston Scientific
BSX
$68.5B
$2.46M 1.43%
+113,500
New +$2.48M
PRGO icon
31
Perrigo
PRGO
$1.43B
$2.44M 1.42%
29,329
-9,624
-25% -$835K
CCXI
32
DELISTED
ChemoCentryx, Inc.
CCXI
$2.41M 1.4%
325,250
-288,640
-47% -$2.08M
AMGN icon
33
Amgen
AMGN
$212B
$2.4M 1.4%
+16,430
New +$2.47M
SYK icon
34
PUT
Stryker
SYK
$133B
$2.4M 1.4%
+20,000
New +$2.3M
IMMU
35
DELISTED
Immunomedics Inc
IMMU
$1.86M 1.09%
+506,978
New +$1.5M
ATNM icon
36
Actinium Pharmaceuticals
ATNM
$27.2M
$1.44M 0.84%
54,969
+1,636
+3% +$51.2K
ADMS
37
DELISTED
Adamas Pharmaceuticals
ADMS
$1.17M 0.68%
69,215
+3,105
+5% +$48K
SRPT icon
38
PUT
Sarepta Therapeutics
SRPT
$1.63B
$960K 0.56%
35,000
-51,500
-60% -$2.07M
AVDL
39
DELISTED
Avadel Pharmaceuticals
AVDL
$950K 0.55%
+91,413
New +$1M
SYRE icon
40
Spyre Therapeutics
SYRE
$8.68B
$820K 0.48%
7,539
+1,366
+22% +$199K
FWP
41
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$769K 0.45%
7,321
-4,837
-40% -$637K
OASM
42
DELISTED
Oasmia Pharmaceutical AB
OASM
$512K 0.3%
182,270
+60,170
+49% +$178K
TMBR
43
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$428K 0.25%
+76
New +$389K
ABBV icon
44
PUT
AbbVie
ABBV
$465B
– –
-50,000
Closed -$3.15M
ASND icon
45
Ascendis Pharma A/S
ASND
$16.7B
– –
-112,497
Closed -$2.26M
CHRS icon
46
Coherus Oncology
CHRS
$222M
– –
-73,053
Closed -$1.96M
MEDP icon
47
Medpace
MEDP
$15.9B
– –
-116,053
Closed -$3.46M
SNY icon
48
Sanofi
SNY
$109B
– –
-223,380
Closed -$8.8M
VKTX icon
49
Viking Therapeutics
VKTX
$3.93B
– –
-849,905
Closed -$1.19M
PFNX
50
DELISTED
Pfenex Inc.
PFNX
– –
-64,556
Closed -$578K
1
2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Sio Capital Management held 55 positions worth $171M, up 18% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sio Capital Management deployed $41.2M of net new capital in Q4 2016, opening 23 new positions and adding to 12 existing holdings. Its largest new stake was GSK: 144,649 shares worth $6.96M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 57% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Philips, an estimated $7.46M trimmed.

  • Sio Capital Management's largest Q4 2016 buy was GSK: 144,649 shares worth $6.96M.
  • Sio Capital Management added most to Advanced Accelerator Applications S.A. in Q4 2016, an estimated $2.61M increase.
  • Sio Capital Management's biggest Q4 2016 reduction was Philips, cutting an estimated $7.46M.
  • Sio Capital Management fully exited Sanofi in Q4 2016, selling an estimated $8.8M.
  • Sio Capital Management's ten largest holdings make up 46% of its $171M portfolio in Q4 2016.
  • Sio Capital Management opened 23 new positions and closed 12 in Q4 2016.
  • Sio Capital Management's portfolio value rose 18% quarter-over-quarter to $171M.

Based on Sio Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.